Long-term safety and efficacy of sodium zirconium cyclosilicate (ZS-9) in the treatment of hyperkalaemia: interim analysis of ZS-005, an open-label phase 3 study
Topic:
Drug therapy, other
Speaker:
Professor S. Anker (Berlin, DE)
Event:
HEART FAILURE 2016
Congress Presentation
About the speaker
Professor Stefan Anker
Charite University Hospital, Berlin (Germany)
171
presentations
10
followers
22 more presentations in this session
Zofenopril combined with xanthine oxidase inhibitors may improve survival in post-myocardial infarction patients as compared to placebo or other ACE-inhibitors
Long-term effects and sustainability of collaborative disease management in systolic heart failure - the extended interdisciplinary network heart failure study
Speaker: Professor C. Angermann (Wurzburg, DE)
An implantable pressure sensor for long-term wireless monitoring of cardiac function -first study in man
Speaker: Doctor J. Baranowski (Linkoping, SE)
Heart failure hospitalisation or cardiovascular death with empagliflozin in patients with type 2 diabetes and high cardiovascular risk: analysis over time in EMPA-REG OUTCOME
Speaker: Doctor D. Fitchett (Toronto, CA)
Characteristics of myocardial deformation parameters and their prognostic impact in patients with hypertrophic cardiomyopathy: a speckle tracking imaging analysis
Speaker: Doctor S. Charfeddine (Sfax, TN)
- …
Access the full session
Clinical Forum - Mon. 23 May 08:30 - Tues. 24 May 12:30
Speakers:
Professor S. Anker, Professor C. Angermann, Doctor J. Baranowski, Doctor D. Fitchett, Doctor S. Charfeddine
About the event
